Net‐benefit regression with censored cost‐effectiveness data from randomized or observational studies
Sign Up to like & getrecommendations! Published in 2022 at "Statistics in Medicine"
DOI: 10.1002/sim.9486
Abstract: Cost‐effectiveness analysis is an essential part of the evaluation of new medical interventions. While in many studies both costs and effectiveness (eg, survival time) are censored, standard survival analysis techniques are often invalid due to… read more here.
Keywords: censored cost; cost; cost effectiveness; net benefit ... See more keywords